51
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

Human neural progenitor and stem cells: US20080107633A1

Pages 377-380 | Published online: 27 Mar 2009
 

Abstract

Background: The application is in the field of neural stem cells (NSCs) and cellular therapy. Objective: It aims at establishing conditions for the isolation and propagation of neural progenitor and stem cells from human fetal tissue, with high rate of growth and high yields of differentiation into the neuronal, astroglial and oligodendroglial pathways. Methods: Neural progenitor and stem cells were isolated from fetal forebrain tissue and propagated as neurospheres, in defined medium in the presence of leukemia inhibitory factor (LIF). Three protocols were designed to differentiate human fetal neural progenitor and stem cells into their progenies. Results: The application claims the generation of human fetal neural progenitor and stem cells with a doubling rate between 5-10 days. It claims the differentiation of the neural progenitor and stem cells in vitro, into neurons, astrocytes and oligodendrocytes with high yields, e.g., 20 to 35% for neuronal cells. Conclusion: The establishment of human neural progenitor and stem cells with high rate of growth and high yields of differentiation provides a source of cells for therapy, particularly for the treatment of neurodegenerative diseases, like Alzheimer's and Parkinson's diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.